Search results

Page title matches

• Bioequivalence
  In [[medicine]] and [[pharmacology]], '''bioequivalence''', or '''therapeutic equivalency''', is "the relative equivalency in the e ==Pharmaceutical bioequivalence==
  5 KB (657 words) - 23:50, 12 July 2010
• Bioequivalence/Definition
  127 bytes (16 words) - 04:51, 7 September 2009
• Bioequivalence/Related Articles
  Auto-populated based on [[Special:WhatLinksHere/Bioequivalence]]. Needs checking by a human.
  489 bytes (62 words) - 11:22, 11 January 2010

Page text matches

• Bioequivalent
  #REDIRECT [[Bioequivalence]]
  28 bytes (2 words) - 23:30, 1 February 2009
• Bioavailability
  '''Bioequivalence''' covers the case where the initial distribution of different drug prepara ...ribution = Subcapter D, Drugs for Human Use, Part 320: Bioavailability and Bioequivalence requirements
  1 KB (140 words) - 01:56, 11 June 2010
• Bioavailability/Related Articles
  {{r|Bioequivalence}}
  274 bytes (29 words) - 14:30, 3 December 2008
• Bioequivalence
  In [[medicine]] and [[pharmacology]], '''bioequivalence''', or '''therapeutic equivalency''', is "the relative equivalency in the e ==Pharmaceutical bioequivalence==
  5 KB (657 words) - 23:50, 12 July 2010
• Bioequivalence/Related Articles
  Auto-populated based on [[Special:WhatLinksHere/Bioequivalence]]. Needs checking by a human.
  489 bytes (62 words) - 11:22, 11 January 2010
• Generic drug/Related Articles
  {{r|Bioequivalence}}
  592 bytes (75 words) - 16:48, 11 January 2010
• Food and Drug Administration/Catalogs/Therapeutic Equivalence Code
  <td width="25%">Products in conventional dosage forms not presenting bioequivalence problems.</td> ...osage forms that are not regarded as presenting either actual or potential bioequivalence problems or drug quality or standards issues. However, all oral dosage form
  14 KB (1,981 words) - 13:19, 2 February 2023
• Pharmacology/Related Articles
  {{r|Bioequivalence}}
  1 KB (150 words) - 19:29, 11 January 2010
• Generic drug
  ...example where pharmagological bioequivalence does not predict therapeutic bioequivalence.<ref name="pmid20547818">{{cite journal| author=Vesga O, Agudelo M, Salazar ...reverse-engineer existing brand name drugs to allow them to manufacture [[bioequivalence|bioequivalent]] versions.
  18 KB (2,553 words) - 13:17, 2 February 2023
• Systematic review/Related Articles
  {{r|Bioequivalence}}
  3 KB (366 words) - 12:22, 18 April 2024
• Food and Drug Administration/Related Articles
  {{r|Bioequivalence}}
  4 KB (505 words) - 16:36, 11 January 2010
• Vancomycin
  ...example where pharmagological bioequivalence does not predict therapeutic bioequivalence.<ref name="pmid20547818">{{cite journal| author=Vesga O, Agudelo M, Salazar
  12 KB (1,633 words) - 12:06, 27 November 2010
• Archive:Monthly Write-a-Thon/March 4, 2009/Uncategorized
  *[[Bioequivalence/Definition]]
  15 KB (1,521 words) - 09:02, 2 March 2024
• Food and Drug Administration
  ...v/cder/ogd/ Office of Generic Drugs] (OGD) is responsible for certifying [[bioequivalence]] of [[generic drug]]s. The [http://www.fda.gov/cder/ob/ Orange Book] cont ...ical to that of the previously approved drug, that its formulation shows [[bioequivalence]] to the previously approved formulation in small human trials, and that th
  40 KB (5,751 words) - 04:07, 19 September 2013